In vivo activity and metabolic fate of 2-(2,3,3-triiodoallyl)tetrazole (ME1401), a novel antifungal agent.

Fukuyasu, H; Orikasa, Y; Kai, F; Inouye, S; Kitasato, I; Yamaguchi, H

Fukuyasu, H; Orikasa, Y; Kai, F; Inouye, S; Kitasato, I; Yamaguchi, H.

Affiliation

Fukuyasu H; Central Research Laboratories, Meiji Seika Kaisha, Ltd., Yokohama, Japan.

Drugs Exp Clin Res ; 15(8): 335-47, 1989.

Article in En | MEDLINE | ID: mdl-2598775

Subject(s)

Antifungal Agents/pharmacology; Azoles/pharmacology; Tetrazoles/pharmacology; Animals; Antifungal Agents/metabolism; Candidiasis/drug therapy; Chromatography, High Pressure Liquid; Female; Fungi/drug effects; Guinea Pigs; Male; Microbial Sensitivity Tests; Skin Absorption; Swine; Swine, Miniature; Tetrazoles/metabolism; Tinea/drug therapy

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Azoles / Tetrazoles / Antifungal Agents Limits: Animals Language: En Journal: Drugs Exp Clin Res Year: 1989 Document type: Article

Search on Google

XML

PubMed Links